Skip to main content
See every side of every news story
Published loading...Updated

Drugmaker shares drop after RFK Jr. tapped to lead HHS

  • Shares in vaccine makers and healthcare firms dropped sharply after Robert F Kennedy Jr was tapped as US Health Secretary, raising investor concerns about the sector.
  • Kennedy has stated he will use the position to crack down on 'Big Pharma,' which has led to fears of increased anti-vaccine rhetoric.
  • Health policy experts believe this could deter Americans from receiving Covid shots and routine immunizations, as noted by former CDC Director Dr. Richard Besser.
Insights by Ground AI
Does this summary seem wrong?

17 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center
50% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

CNBC broke the news in United States on Thursday, November 14, 2024.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal